Antenatal lung maturation--should we all be using thyrotropin-releasing hormone? 1995

N M Fisk, and M J Peek
Institute of Obstetrics and Gynaecology, Royal Postgraduate Medical School, Queen Charlotte's and Chelsea Hospital, London, United Kingdom.

Thyrotropin-releasing hormone (TRH) appears to be a promising antenatal therapy to help reduce neonatal lung disease. Clinical trials, however, show differing results. At present the optimum dosage, frequency and method of administration have not been established. TRH has been shown significantly to elevate blood pressure in patients with preeclampsia suggesting it should not be used in this group. Moreover concerns over its use in growth retarded fetuses and its long-term neonatal effects have not been addressed. Further trials are needed before routine clinical use can be recommended.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D012127 Respiratory Distress Syndrome, Newborn A condition of the newborn marked by DYSPNEA with CYANOSIS, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, mostly frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. Infantile Respiratory Distress Syndrome,Neonatal Respiratory Distress Syndrome,Respiratory Distress Syndrome, Infant
D005325 Fetal Organ Maturity Functional competence of specific organs or body systems of the FETUS in utero. Fetal Maturity, Functional,Functional Fetal Maturity,Maturity, Fetal Organ,Maturity, Functional Fetal,Organ Maturity, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013973 Thyrotropin-Releasing Hormone A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND. Protirelin,Thyroliberin,Abbott-38579,Antepan,Proterelin Tartrate,Proterelin Tartrate Hydrate,Protirelin Tartrate (1:1),Relefact TRH,Stimu-TSH,TRH Ferring,TRH Prem,Thypinone,Thyroliberin TRH Merck,Thyrotropin-Releasing Factor,Thyrotropin-Releasing Hormone Tartrate,Abbott 38579,Abbott38579,Hydrate, Proterelin Tartrate,Prem, TRH,Stimu TSH,StimuTSH,TRH, Relefact,Tartrate Hydrate, Proterelin,Thyrotropin Releasing Factor,Thyrotropin Releasing Hormone,Thyrotropin Releasing Hormone Tartrate

Related Publications

N M Fisk, and M J Peek
November 2018, Journal of paediatrics and child health,
N M Fisk, and M J Peek
January 1989, Obstetrics and gynecology,
N M Fisk, and M J Peek
October 1988, Journal of applied physiology (Bethesda, Md. : 1985),
N M Fisk, and M J Peek
July 2013, JAMA internal medicine,
N M Fisk, and M J Peek
June 2018, Clinics in perinatology,
N M Fisk, and M J Peek
December 1998, Clinics in perinatology,
Copied contents to your clipboard!